Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status

• Published in: Journal of the American Heart Association Vol. 13; no. 9; p. e034109
• Main Authors: Xu, Xin, Ren, Qing‐Wen, Chandramouli, Chanchal, Ng, Ming‐Yen, Tsang, Christopher Tze‐Wei, Tse, Yi‐Kei, Li, Xin‐Li, Liu, Ming‐Ya, Wu, Mei‐Zhen, Huang, Jia‐Yi, Cheang, Iok‐Fai, Yang, Jie‐Fu, Wang, Fang, Lam, Carolyn S.P., Yiu, Kai‐Hang
• Format: Journal Article
• Language: English
• Published: England John Wiley and Sons Inc 07.05.2024; Wiley
• Subjects: diabetes; HbA1c variability; heart failure; Original Research; heart failure; diabetes; HbA1c variability

The effect of glycated hemoglobin (HbA ) variability on adverse outcomes in patients with heart failure (HF) is unclear. We aim to investigate the predictive value of HbA variability on the risks of all-cause death and HF rehospitalization in patients with HF irrespective of their diabetic status. U...